Literature DB >> 1622730

Demonstration of systemic lymphnodes by bone scintigraphy in amyloidosis.

K Itoh1, Y Baba, K Taneichi.   

Abstract

We report a case of primary amyloidosis with calcification of systemic lymphnodes which were demonstrated as positives by bone scintigraphy. Positive sites delineated by bone scintigraphy would seem likely to reflect avid calcification of amyloid deposits. The discovery of positive systemic lymphnodes by bone scintigraphy is very rare in a routine study and may allow for amyloidosis in a differential diagnosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1622730     DOI: 10.1007/bf03164649

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  7 in total

1.  Technetium-99m-diphosphonate accumulation in amyloid.

Authors:  J D VanAntwerp; R E O'Mara; M J Pitt; S Walsh
Journal:  J Nucl Med       Date:  1975-03       Impact factor: 10.057

2.  Extensive soft tissue uptake of bone tracer in amyloidosis.

Authors:  K J Lee; A E Southee; J G Morris; M A Rossleigh
Journal:  Clin Nucl Med       Date:  1988-09       Impact factor: 7.794

Review 3.  Amyloidosis: clinical, pathologic, and biochemical characteristics.

Authors:  M Skinner; A S Cohen
Journal:  Monogr Pathol       Date:  1983

4.  Localization of Tc-99m-MDP in amyloidosis of the breast.

Authors:  G L McLellan; J H Stewart; S Balachandran
Journal:  Clin Nucl Med       Date:  1981-12       Impact factor: 7.794

5.  Hepatic uptake of Tc-99m-labeled diphosphonate in amyloidosis: case report.

Authors:  J A Vanek; S A Cook; R M Bukowski
Journal:  J Nucl Med       Date:  1977-11       Impact factor: 10.057

6.  Soft tissue uptake of bone seeking radionuclide in amyloidosis.

Authors:  R A Yood; M Skinner; A S Cohen; V W Lee
Journal:  J Rheumatol       Date:  1981 Sep-Oct       Impact factor: 4.666

Review 7.  Amyloidosis (AL). Clinical and laboratory features in 229 cases.

Authors:  R A Kyle; P R Greipp
Journal:  Mayo Clin Proc       Date:  1983-10       Impact factor: 7.616

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.